The Effect of Probiotic Supplementation on Mental Health in Healthy Volunteers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-06

Study Completion Date

2024-07-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Probiotics are "live microorganisms which when administered in adequate amounts confer a health benefit on the host". Accumulating evidence indicates their effect in mental health restoration. Beneficial neuropsychological and psychobiological effects are particularly well substantiated in clinical samples. However, it is not clearly documented whether probiotic supplementation reduces depressive and anxiety symptoms in healthy volunteers experiencing temporal deterioration in mental functioning while facing a stressful event. The combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 is particularly well studied in terms of its central nervous system action with significantly deciphered mechanism. As a result, this combination is particularly promising to study the effect of mental health improvement in healthy volunteers facing a stressful event.

The aim of this project is to assess the impact of a 8-week supplementation with probiotic combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 strains in the daily dose of 3 × 10\^9 colony forming units on mental health measures and oral microbiota composition and metabolome in healthy young adults facing a psychologically stressful event. The aim will be achieved by comparing the probiotic combination supplement to placebo in a randomized triple-blind controlled trial settings with a participant allocation ratio of 1:1.

The summer academic examination session and the upcoming first take of the final exam in pharmacology at third year of medical studies will be a model of a stressful event. The participants will supplement their diets with probiotic/placebo for 8 weeks before the exam. After giving written informed consent, before the supplementation (relatively stress-free time period in terms of academic activities) the participants will provide background sociodemographic, anthropometric and psychometric data. At that time, participants will also give samples of saliva to assess cortisol and selected cytokines concentrations as well as salivary microbiome and metabolome. At the end of supplementation, a day before the final exam, participants will donate salivary samples and do psychometric tests for the second time to assess the same parameters as at the beginning of the study. Participants will also do a pre-exam test in pharmacology (not considered a formal academic assessment) as a comparator for the results of the formal examination held a day after.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Impact of Selected Probiotic Bacteria on Gut Microbiota, Stress Indicators and Nutritional Status of Young Adults

NCT06860581

Healthy Volunteers Young Adult Women

COMPLETED NA

The Influence of Probiotic Supplementation on the Severity of Anxiety and Depressive Symptoms, as Well as the Function and Composition of Gut Microbiota, Metabolic, Inflammation, and Oxidative Stress Markers in Patients With Depression

NCT05717946

Depression Anxiety

UNKNOWN PHASE2

The Influence of Probiotic Supplementation on Depressive Symptoms, Inflammation and Oxidative Stress Parameters and Faecal Microbiota in Patients With Depression Depending on Metabolic Syndrome Comorbidity

NCT04756544

Depressive Disorder Depression Anxiety +3 more

UNKNOWN PHASE3

The Effects of Probiotic Supplementation on State and Trait Stress, Anxiety, and Depression Symptoms in Stressed Adults

NCT07216729

Anxiety Symptoms Perceived Stress Depressive Symptoms

COMPLETED NA

Stress & Anxiety Dampening Effects of a Probiotic Supplement Compared to Placebo in Healthy Subjects

NCT03494725

Healthy Stress, Psychological

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Stress-related Problem Depression Anxiety

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Healthy medical students are assigned

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Probiotic

Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 combination probiotic - encapsulated

Group Type EXPERIMENTAL

Lactobacillus helveticus R0052 and Bifidobacterium longum R0175

Intervention Type DIETARY_SUPPLEMENT

8-week supplementation (56 days); 3 × 10\^9 CFU/day

Placebo

Mixture of potato starch and magnesium stearate (the excipients that are present in the tested product) - encapsulated

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

8-week supplementation (56 days)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lactobacillus helveticus R0052 and Bifidobacterium longum R0175

8-week supplementation (56 days); 3 × 10\^9 CFU/day

Intervention Type DIETARY_SUPPLEMENT

Placebo

8-week supplementation (56 days)

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* status of a third-year medical student at the Faculty of Medicine of the Medical University of Lodz
* age (18-30 years)
* high motivation and no formal obstacles to sit the first take of the final exam in pharmacology
* Body mass index of 18-25 kg/m2

Exclusion Criteria

* chronic dental diseases (in particular periodontal diseases), neurological, psychiatric, cardiological, gastroenterological, endocrinological, immunological, inflammatory or infectious diseases or disorders
* psychiatric or neurological diagnosis - within the last 1 year
* immune disorders or possible immunodeficiency - within the last 5 years
* previous bariatric surgery - within the last 5 years
* hospitalization - within the last 3 months
* presence of central venous catheters
* use of enteral nutrition (feeding tube or nutritional fistula)
* pregnant or planning to become pregnant in the next 3 months
* breast-feeding
* occurrence of an allergic reaction - within the last 3 months
* hypersensitivity to potato starch or magnesium stearate
* chronic use of any medicinal products - within the last 3 months
* use of systemic antibacterial or antifungal drugs - within the last 1 month
* alcohol abuse (≥ 20 g or ≥ 40 g of alcohol per day for women and men, respectively) - within the last 3 months
* abuse of narcotic or psychotropic substances - within the last 3 months
* regular smoking of tobacco or other nicotine products, including e-cigarettes (\> 5 cigarettes or equivalents per day - within the last 3 months)
* use of probiotic or prebiotic preparations - within the last 1 month
* a vegan diet or any unusual diet

Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes